Vacuolar-type H+-transporting ATPase (V-ATPase)

The lysosomal/endosomal acidification machinery is a multi-subunit system, primarily centered on the Vacuolar-type H+-transporting ATPase (V-ATPase), that maintains the acidic environment (pH 4.5–5.0) required for organelle function (NIH, 2020; Biologists.com, 2014). This machinery couples ATP hydrolysis to proton pumping, creating a gradient essential for the activity of over 60 hydrolytic enzymes and for nutrient sensing via the mTORC1 pathway (NIH, 2020; ResearchGate, 2020). Dysregulation of this process is a hallmark of neurodegenerative diseases like Alzheimer’s and Parkinson’s, where acidification failure prevents the degradation of toxic protein aggregates (Translational Neurodegeneration, 2023; NIH, 2016). In cancer, V-ATPases are often upregulated or translocated to the plasma membrane to acidify the tumor microenvironment, promoting invasion and drug resistance (MDPI, 2020; NIH, 2025). Pharmacological modulation includes V-ATPase inhibitors like bafilomycin A1, used to block autophagy and viral entry, and re-acidifying agents like EN6 that aim to restore lysosomal health (NIH, 2020; ResearchGate, 2026). However, the ubiquitous role of V-ATPases in processes like bone resorption and renal pH regulation presents significant challenges for achieving therapeutic selectivity (NIH, 2009; PLOS, 2016).

Other names

Lysosomal/endosomal acidification machineryVacuolar proton pumpV-type ATPaseH+-transporting ATPaseEndosomal/lysosomal proton pump

Drugs targeting the lysosomal/endosomal acidification machinery primarily act by inhibiting or modulating the Vacuolar-type H+-transporting ATPase (V-ATPase). Inhibitors like bafilomycin A1 and concanamycin A bind to the V0 or V1 domains of the pump, preventing the translocation of protons into the organelle lumen. This increases the intraluminal pH, thereby inactivating acid-dependent hydrolases and disrupting autophagic flux. Conversely, re-acidifying agents and V-ATPase activators, such as EN6, aim to restore the acidic environment in diseased states where acidification is compromised, thereby enhancing the clearance of toxic substrates.